Keeley Teton Advisors LLC lessened its holdings in shares of CareTrust REIT, Inc. (NASDAQ:CTRE - Get Rating) by 2.2% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 384,413 shares of the real estate investment trust's stock after selling 8,676 shares during the quarter. CareTrust REIT comprises approximately 1.0% of Keeley Teton Advisors LLC's portfolio, making the stock its 13th biggest holding. Keeley Teton Advisors LLC owned 0.40% of CareTrust REIT worth $6,962,000 at the end of the most recent quarter.
→ E-mini S&P 500 Futures, The Advantage of Thinking Small (From RJO Futures)
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CTRE. State Street Corp boosted its position in CareTrust REIT by 12.1% during the first quarter. State Street Corp now owns 5,959,881 shares of the real estate investment trust's stock worth $116,638,000 after purchasing an additional 641,444 shares during the period. William Blair Investment Management LLC bought a new position in CareTrust REIT during the second quarter worth about $9,762,000. Monarch Partners Asset Management LLC bought a new position in CareTrust REIT during the third quarter worth about $4,424,000. Great West Life Assurance Co. Can bought a new position in CareTrust REIT during the third quarter worth about $3,643,000. Finally, First Trust Advisors LP boosted its position in shares of CareTrust REIT by 411.5% in the first quarter. First Trust Advisors LP now owns 234,556 shares of the real estate investment trust's stock valued at $4,527,000 after acquiring an additional 188,701 shares during the period. Institutional investors own 85.01% of the company's stock.
A number of equities analysts have recently commented on CTRE shares. KeyCorp raised their price objective on shares of CareTrust REIT from $21.00 to $22.00 and gave the company an "overweight" rating in a research report on Tuesday, February 14th. Raymond James cut their price objective on shares of CareTrust REIT from $23.00 to $22.00 and set a "strong-buy" rating for the company in a research report on Tuesday, November 1st. Four investment analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $20.90.
Shares of CTRE opened at $20.70 on Tuesday. The firm's 50 day simple moving average is $19.58 and its 200 day simple moving average is $19.56. The company has a market capitalization of $2.06 billion, a P/E ratio of -258.75 and a beta of 1.16. The company has a debt-to-equity ratio of 0.85, a current ratio of 0.56 and a quick ratio of 0.56. CareTrust REIT, Inc. has a 1-year low of $15.90 and a 1-year high of $22.46.
The firm also recently declared a quarterly dividend, which was paid on Friday, January 13th. Shareholders of record on Friday, December 30th were paid a dividend of $0.275 per share. This represents a $1.10 annualized dividend and a dividend yield of 5.31%. The ex-dividend date was Thursday, December 29th. CareTrust REIT's dividend payout ratio (DPR) is presently -1,375.00%.
CareTrust REIT, Inc operates as real estate investment company, which engages in the ownership, acquisition, and leasing of healthcare-related properties. It offers independent living, memory care, and assisted, and skilled nursing facilities. The company was founded on October 29, 2013 and is headquartered in San Clemente, CA.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider CareTrust REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CareTrust REIT wasn't on the list.
While CareTrust REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by entering your email address below.
